|1.||Bolli, Geremia B: 4 articles (06/2011 - 01/2006)|
|2.||Dippel, F-W: 2 articles (12/2015 - 03/2009)|
|3.||Qayyum, Rehan: 2 articles (04/2011 - 10/2008)|
|4.||Davies, M J: 2 articles (12/2009 - 08/2008)|
|5.||Alemzadeh, Ramin: 2 articles (08/2009 - 05/2005)|
|6.||Smith, Steven A: 2 articles (03/2008 - 01/2005)|
|7.||de Boer, H: 2 articles (09/2006 - 03/2004)|
|8.||Jansen, M: 2 articles (09/2006 - 03/2004)|
|9.||Verschoor, L: 2 articles (09/2006 - 03/2004)|
|10.||Schwartz, Sherwyn: 2 articles (01/2006 - 11/2004)|
|1.||Hypoglycemia (Reactive Hypoglycemia)
05/01/2008 - "The use of these long-acting insulin analogues appears to be associated with a reduced incidence of hypoglycemia, especially at night. "
07/01/2004 - "The use of this long-acting insulin analogue appears to be associated with a reduced incidence of hypoglycemia, especially at night. "
01/01/2014 - "Clinical trials have shown that this ultra long-acting insulin analogue administered in a flexible dosage treatment, reached a good glycaemic control with no increase on hypoglycemia risk. "
01/01/2007 - "Randomized clinical trials suggest that the long-acting insulin analogs are associated with a lower risk for nocturnal hypoglycemia than neutral protamine Hagedorn without sacrificing glycemic control."
04/01/1997 - "To study this, groups of rats were injected with approximately 25 U/kg ultralente insulin daily at 1700 for 8 days to maintain hypoglycemia. "
01/01/2001 - "Efficacy of protamine zinc insulin for treatment of diabetes mellitus in cats."
10/01/1969 - "[Comparative efficacy of long-acting insulin preparations in diabetes mellitus]."
03/01/2009 - "The purpose of this study was to review studies reporting on quality of life and treatment satisfaction of patients with diabetes mellitus being treated with long-acting insulin analogues. "
06/01/1937 - "Control of Diabetes Mellitus with Protamine Zinc Insulin in Surgery : (Based Upon a Study of 25 Cases)."
01/01/2010 - "Long-Acting Insulin Analogues for the Treatment of Diabetes Mellitus: Meta-analyses of Clinical Outcomes."
|3.||Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/01/1984 - "The aim was to study the effect of dose on subcutaneous absorption of semisynthetic human Lente-type insulin (Monotard HM) in IDDM patients. "
03/01/2008 - "Type 1 diabetes mellitus treatment includes plain substitution and individualization for short-acting plus long-acting insulin according to the physician's assistance, besides regular practice of physical activities and diet orientations. "
01/01/2008 - "Intermediate acting versus long acting insulin for type 1 diabetes mellitus."
06/01/1995 - "Twelve cats with insulin-dependent diabetes mellitus were treated with lente insulin. "
09/01/2011 - "Long-acting insulin treatments with varying clinical benefits are currently available for patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). "
09/01/2006 - "The aim of this study was to investigate whether a regimen free of long-acting insulin can provide long-term glycaemic control without causing weight gain. "
03/01/2004 - "To test the concept that regain of glycaemic control can be achieved without causing weight gain, using a regimen free of long-acting insulin. "
11/01/1984 - "Peripherally administered, long acting insulin stimulates weight gain and food intake. "
01/01/1983 - "Rats were made to overeat and gain weight (about 50 g) by long-acting protamine zinc insulin (PZI) treatment. "
10/01/1979 - "Effect of protamine zinc insulin on feed intake and weight gain in broiler chicks."
|5.||Body Weight (Weight, Body)
02/01/1985 - "After an overnight fast 0.4 U of intermediate acting insulin (Monotard MC/NOVO INDUSTRIES) per kg body weight were injected subcutaneously. "
01/01/1978 - "Daily administration of 2 U protamine zinc insulin (PZI)/100 g body weight to diabetic rats returned these measurements to normal levels. "
09/01/2007 - "STZ+insulin-treated group C diabetic rats were additionally treated with subcutaneous injections of lente insulin (0.5 U/kg body weight) daily from Day 10 to Day 30 of our 40-day study period. "
09/01/1983 - "Rats were given daily injections of protamine-zinc insulin (PZI) that increased food intake and body weight. "
01/01/1982 - "Lean rats were then given daily injections of protamine zinc insulin at 3 doses: 0.25, 1.25, and 4.0 U.100 g body wt-1.day-1 for 3 wk. Obese rats received identical amounts as corresponding lean controls independent of body weights. "
|2.||glargine (insulin glargine)
|4.||insulin detemir (Levemir)
|6.||Hypoglycemic Agents (Hypoglycemics)
|8.||insulin LISPRO (Humalog)
|9.||Blood Glucose (Blood Sugar)
|2.||Carbohydrate-Restricted Diet (Low Carbohydrate Diet)
|3.||Communication Aids for Disabled (TDD)